Fermentation & cell culture: Production of Biopharmaceuticals

Tuesday, August 13, 2013: 8:30 AM-11:30 AM
Nautilus 5 (Sheraton San Diego)
Convener:
Tom Kelleher - Amgen, Thousand Oaks, CA
Co-Convener:
Tiffany D. Rau - Eli Lilly, Lake Charles, LA



8:30 AM
S61
Biosimilar MAb Production in Stainless Steel and Single-Use Bioreactors
H. Henry Lamb1, Sharyn L. Farnsworth2 and Stewart McNaull2, (1)Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, (2)Upstream Process Development, Fujifilm Diosynth Biotechnologies, Cary, NC
9:30 AM
Break
10:00 AM
S63
Scale Free Manufacturing Model using Perfusion
Gael Peron1, Wilson Lee1 and Olivier Berteau2, (1)Charter Medical, Ltd, Winston-Salem, NC, (2)APIcells Inc, Lowell, MA
10:30 AM
S64
Impact of Regulatory Guidances on Biopharmaceutical Cell Culture
Tom Kelleher, Global Process Engineering and Process Development, Amgen, Thousand Oaks, CA
11:00 AM
S65
Challenges Faced During the Flublok Approval Process
Penny Post, Regulatory, Protein Sciences Corporation, Meriden, CT
See more of: Invited Oral Papers